Breaking 7% Reception @ Jefferies

​Breaking 7% is a network connecting women across the life sciences ecosystem.

For the first time since our launch in 2023, we are opening our community to a broader audience through a new event format: an invitation-only evening bringing together 80 exceptional women from across venture capital, limited partners, business development and startup leadership.

The evening will combine networking over dinner and drinks with a moderated panel discussion featuring leading voices from each sector, designed to spark conversation across the life sciences ecosystem.

​The Panel

​Deborah Baron - Senior Vice President, Worldwide Business Development, Pfizer (BD)

​Henrijette Richter - Managing Partner, Sofinnova Partners (VC)

​Laura Shawver - CEO Birdseye Therapeutics (CEO)

​Stephanie Heller - Co-founder and Managing Partner, Bootstrap Europe (LP)

​The Ask
To help grow and strengthen the Breaking 7% community, we ask each invitee to nominate one exceptional woman from their network to attend as their guest (you will be prompted during registration).

​Co-hosts: Earlybird Health, F-Prime Capital, Glide Healthcare, British Business Bank, Forbion, Jeito, Goldman Sachs, Oxford Science Enterprises, Sound Bioventures, Ysios Capital, M Ventures

​Sponsors: Goodwin Procter, Coulter Partners

​In collaboration with: SEC BioCapital Network, Invest in Equity